Clinical trials · Illinois
Celiac Disease clinical trials in Illinois
We’re tracking 4 recruiting celiac disease studies with a site in Illinois — including Phase 2 studies, each written for real people, not researchers.
Recruiting studies in Illinois
- NCT07239336RecruitingPhase 2
Study of DONQ52 for active celiac disease
This trial tests a new drug called DONQ52 in people with active celiac disease who still have symptoms despite following a gluten-free diet. The goal is to see if DONQ52 can help reduce damage to the small intestine and improve gluten-related symptoms.
Glenview, IllinoisAges 18–75 - NCT05680012Recruiting
Testing how gluten affects healing in celiac disease
This study looks at how the gut lining “tissues” are affected during gluten eating versus avoiding gluten in people with celiac disease. It may help researchers understand what drives healing and tissue damage in celiac disease.
Chicago, IllinoisAges 18–75 - NCT06059716Recruiting
Gluten detection and education for new celiac diagnosis
This study helps people newly diagnosed with celiac disease learn to use a gluten-detection device and get education to better manage their diet and health.
Chicago, IllinoisAges 18–75 - NCT06587828Recruiting
Looking at immune cells in people with autoimmune disease
This study collects blood, tissue, and other samples from people with autoimmune diseases like Crohn's disease, multiple sclerosis, or lupus. Researchers will study your immune cells (T cells) to learn what they are attacking, which could lead to better treatments in the future.
Skokie, IllinoisAges 18 years+
Celiac Disease trials by city in Illinois
Where these studies are running in Illinois
Institutions with a site for the recruiting celiac disease studies listed above.
- University of Chicago · 2 studies
- Arnold Arthritis & Rheumatology
- GI Alliance
- GI Alliance - Glenview
- Rockford Gastroenterology Associates, Ltd.
What taking part in a celiac disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Celiac Disease trials in other states
Common questions
- Are there celiac disease clinical trials in Illinois?
- Yes. We're currently tracking 4 recruiting celiac disease studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a celiac disease study in Illinois?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Illinois to take part?
- Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a celiac disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New celiac disease studies open in Illinois regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.